Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a progressing disease, with lung but not gut microbiota implicated in its etiology. Here the authors compare the stool from patients with COPD and healthy controls to find specific gut bacteria and metabolites associated with active disease, thereby hi...
Guardado en:
Autores principales: | Kate L. Bowerman, Saima Firdous Rehman, Annalicia Vaughan, Nancy Lachner, Kurtis F. Budden, Richard Y. Kim, David L. A. Wood, Shaan L. Gellatly, Shakti D. Shukla, Lisa G. Wood, Ian A. Yang, Peter A. Wark, Philip Hugenholtz, Philip M. Hansbro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c37d126ac6bf4df5ae3b32232a535530 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The metabolomics of psoriatic disease
por: Yan D, et al.
Publicado: (2017) -
LF-15 & T7, synthetic peptides derived from tumstatin, attenuate aspects of airway remodelling in a murine model of chronic OVA-induced allergic airway disease.
por: Karryn T Grafton, et al.
Publicado: (2014) -
Comprehensive Metabolomics Study in Children With Graves’ Disease
por: Qin Xia, et al.
Publicado: (2021) -
Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
por: Eleanor Sinclair, et al.
Publicado: (2021) -
Metabolomic Evaluation of Chronic Periodontal Disease in Older Adults
por: Wellington F. Rodrigues, et al.
Publicado: (2021)